BCR on NYSE [C R Bard] Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : BCR on NYSE [C R Bard]

BCR 331.24

0.0%

Dec 29 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 PreviousNext

From: jeeee4	4/22/2010 12:43:09 PM
	of 5

Doing some math on BCR earnings The trailing 12 months PE is 18.44 while the forward PE is 13.83, which indicates an expected year-on-year earnings gain of 33% and a forward PE/Growth (PEG) of only .41 (normal PEG = 1). Obviously these PEs have not priced in such an earnings growth rate. Thus, the stock could go x2 and still be reasonably priced. My experience is that over time investors’ scans pick up stocks selling at low PE vs. their earnings growth rate. When this happens, the stock corrects upward very rapidly.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 PreviousNext